Gene Therapy Development for Glaucoma

0
1K

Glaucoma is a complex disease, and currently the only way to maintain patient health is by lowering intraocular pressure. Gene therapy to treat the disease is rapidly evolving. This is a much needed area of glaucoma treatment that can be applied to a variety of glaucoma types.

A major risk factor for glaucoma is high IOP and causes blindness primarily due to RGC damage and death. Therefore, Ace Ophthalmology provides gene therapy development services for glaucoma, targeting candidate genes related to IOP and RGC, as well as many other related genes and pathways.

Learn more:glaucoma gene delivery system development service

Zoeken
Werbung
Categorieën
Read More
Other
How does the Queen Team help buyers find the right homes
Finding the right property in a new neighborhood often starts late at night with a coffee and a...
By The Jennifer Queen Team 2026-08-10 04:19:36 0 40
Health
What to Consider When Choosing the Best Trichologists in Dubai
Hair and scalp concerns can develop for many different reasons, including hereditary hair loss,...
By Muhammad Faizan 2026-08-10 05:08:57 0 41
Other
Global Portable Charger Market Size and Share
Decisions Advisors Global Portable Charger Market Study 2025-2035, by Segment. A new Portable...
By Akshay Dhage 2026-08-10 05:06:01 0 14
Other
Gullian Barre Syndrome market is anticipated to expand from $730.2 million in 2024 to $1,268.5 million by 2034, growing at a CAGR of approximately 5.7% supported by neurological research.
Market Overview The Gullian Barre Syndrome market is developing as healthcare systems place...
By Arnav Dubale 2026-08-10 05:39:45 0 3
Other
Defending Your Livelihood: Why Exceptional Hardship Demands Elite Legal Strategy in 2026
The reality of driving in the United Kingdom has shifted dramatically over the past few years....
By UK Immigration Solicitors 2026-08-10 05:32:15 0 37